The Academy partnered with ASOPRS and NANOS to submit formal written comments to five Medicare administrative contractors on proposed coverage policies for botulinum toxin injections that could override your clinical judgment on treatment decisions.
Member exclusive - Locked
Log in to keep reading.
Join AAO to get unlimited access to content. See member benefits or join today.